Table 4 Effect size of sST2/LVMI on the composite outcome in prespecified and exploratory subgroups
Characteristic | No of participants | Effect size (95% CI) | P value | P for interaction |
|---|---|---|---|---|
Age (years) | ||||
 < 60 | 33 | 1.13 (0.93, 1.38) | 0.2213 | 0.0380 |
 ≥ 60 | 12 | 3.77 (0.93, 15.26) | 0.0633 | |
Gender | ||||
 Female | 9 | 4.18 (1.08, 16.16) | 0.0382 | 0.0140 |
 Male | 36 | 1.17 (0.95, 1.45) | 0.1446 | |
Systolic blood pressure (mmHg) | ||||
 < 140 | 35 | 1.20 (0.96, 1.51) | 0.1139 | 0.0466 |
 ≥ 140 | 10 | 3.66 (0.98, 13.65) | 0.0529 | |
Serum uric acid (μmol/L) | ||||
 < 416 | 14 | 2.43 (1.39, 4.25) | 0.0018 | 0.0052 |
 ≥ 416 | 31 | 1.09 (0.83, 1.42) | 0.5386 | |
High density lipoprotein cholesterol, mean (SD) (mmol/L) | ||||
 < 0.9 | 22 | 1.16 (0.86, 1.56) | 0.3251 | 0.0361 |
 ≥ 0.9 | 21 | 2.16 (1.27, 3.67) | 0.0042 | |